try nutrition. In ovo injection has proved to be a cost-effective approach for vaccine administration to fertilized eggs in current commercial hatcheries. This has led to an interest in pursuing more research exploring the use of other nutrients that can be injected into eggs. This process is explained as in ovo feeding [5] and refers to the administration of compounds into the embryonic amnion that are subsequently orally consumed by the embryo, which subsequently brings the internal nutrients into immediate contact with tissues of the digestive system [5] . lCarnitine has been recognized as facilitating the transfer of fatty acyl groups from the yolk into the tissues of embryonic chicks via the yolk sac membrane, which in turn allows more usable energy to be available to the chick [6] . At the end of incubation, the embryo uses its energy reserves because of the high demand for glucose to fuel all the hatching activities; therefore, the chick requires extra energy for the pipping process [7, 8] . Recently, it has been shown that l-carnitine can increase the moisture of the pipping muscle [9] . The levels of chain-esterified carnitine in the liver, brain, and heart are also at the maximum level at 18 d of incubation, which suggests the importance of fatty acid oxidation for energy production in embryos [10] .
Dietary l-carnitine supplementation in poultry has been reported previously [11] [12] [13] [14] [15] . Dietary l-carnitine supplementation causes the generation of adenosine triphosphate energy and improves energy utilization by promoting β-oxidation of fatty acids [10] . Therefore, supplementation of l-carnitine in the diet reduces the amounts of long-chain fatty acids available for esterification to triacylglycerols and their subsequent storage in adipose tissue [16] . Excess body fat in broilers is of concern, and feeding l-carnitine to breeder hens that are 21 wk of age or older has shown to decrease carcass fat and increase breast meat yield in progeny fed diets high in amino acid density [13] . This study was focused on the effects of l-carnitine provided via in ovo injection, followed by additional supply through dietary supplementation.
MATERIALS AND METHODS
All bird procedures were approved by the Mississippi State University Institutional Animal Care and Use Committee.
Incubation and Treatments
Ross × Ross 708 broiler hatching eggs were obtained from a local commercial source. On the third day after collection, 1,440 eggs were individually weighed, and all cracked, dirty, and misshapen eggs were discarded. Eggs were set on 10 tray levels of a Jamesway Model PS 500 single-stage incubator [17] . On each tray level, which corresponded to a replicate unit, all 9 treatment groups (in ovo injection and feed supplement combinations) were represented. Therefore, a total of 144 eggs were set on each tray level, with 16 eggs randomly assigned to each treatment group. Wet and dry bulb temperatures were recorded using data loggers placed on levels 1, 5, and 10 of the incubator. Average dry and wet bulb temperatures were maintained at 37.5 ± 0.1 and 28.9 ± 0.1°C, respectively, throughout incubation. On d 14 of incubation, eggs were candled and eggs that were unfertilized, that were contaminated, or that contained dead embryos were discarded and recorded.
On d 18 of incubation, the embryonic amnion was injected according to the following treatment descriptions: 1) noninjected control, 2) shell perforation control with no diluent delivered (dry punch), 3) injection of 100 μL of diluent control, 4) injection with 100 μL of diluent containing 8 mg of supplemental l-carnitine, 5) injection with 100 μL of diluent containing 16 mg of supplemental l-carnitine, or 6) injection with 100 μL of diluent containing 32 mg of supplemental l-carnitine. After hatch, 3 treatment groups (treatments 7, 8, and 9) were added for the grow-out period. Chicks hatched from eggs that were injected with l-carnitine at each of the 3 dosages (treatments 4, 5, and 6) received feed that was supplemented with 50 ppm of l-carnitine, whereas control treatments (treatments 1, 2, and 3) were fed unsupplemented l-carnitine feed.
Injection and Hatching
Injections of eggs were conducted immediately before transfer on d 18 of incubation, using a modified Intelliject automated multiegg injector [18] . All eggs belonging to a particular treatment were injected and were then randomly placed as groups (16 eggs per group) among the corresponding 10 replicate hatching baskets of a Jamesway Model PS 500 hatcher unit [19] . The injector was equipped with an automated cleaning cycle and was flushed and cleaned after each treatment group of eggs to prevent cross-contamination, and the machine was primed with each of the treatment solutions before injecting the current treatment. A 100-μL volume of treatment was injected into the large end of each egg. A validation test using a water-soluble dye was conducted to determine the injection site. A total of 100 embryonated eggs were opened immediately after injection on d 18 of incubation. A total of 88 eggs were injected in the amnion, 7 were injected subcutaneously, 4 were injected intramuscularly, and 1 was injected into an eye.
Grow-Out
On d 0 posthatch (21 d of incubation), 12 chicks belonging to the same treatment replicate group were randomly selected and transferred to 1 of 90 floor pens in a broiler grow-out house. On a daily basis, the condition and mortality of birds were monitored, and the temperature and weights of dead birds were recorded. Birds were raised on 3 lx of light for 24 h for the first 5 d and thereafter on 20 h of light per day. Chicks were provided ad libitum access to feed and water, and the use of 50 ppm of supplemental l-carnitine was in accordance with the previously indicated treatment designations. The compositions of the experimental diets are shown in Table 1 , and were all formulated to meet or exceed NRC recommendations [20] throughout the grow-out period. The feed was mixed as a common basal diet, and aliquots were then taken from this common diet, split in 2, and blended with either 50 ppm of l-carnitine or 50 ppm of an inert filler (sand).
Data Collection
Hatch time for each treatment replication was monitored every 12 h from 19.5 to 21.5 d. Hatchability was calculated and expressed as a percentage of the fertilized eggs. After hatch, dead birds and their weights were recorded. Birds and feed were weighed, and birds were counted in each treatment replicate pen on d 21 and 45 of grow-out to calculate mean BW gain and feed conversion. On d 45 of posthatch growout, 6 birds (3 males and 3 females) from each treatment replication were randomly selected, individually weighed, and processed. Weights of the carcass, abdominal fat pad, back half, and breast meat were recorded.
Statistical Analysis
A randomized complete block experimental design was used for the incubational and growout components of the study (d 0). Incubator tray levels and areas of the grow-out house represented specific replicate units and were considered blocks, with all 9 treatments equally represented within each replicate unit. When chicks were moved to the grow-out house, those belonging to the same treatment replicate group were randomly assigned to an individual pen. The PROC REG option of SAS was used to regress the means for time of hatch and hatchabil- 
RESULTS AND DISCUSSION
Time of hatch and hatchability of fertilized eggs for each treatment group are provided in Table 2 . Mean length of incubation and hatchability of fertilized eggs were not significantly different between individual treatments. In agreement with these results, Keralapurath et al. [22] showed no significant effects on hatch time attributable to l-carnitine levels at 0.5, 2.0, and 8.0 mg/100 μL of commercial diluent. However, hatchability was low in comparison with other research [9, 16, [23] [24] [25] . In the current study, all the eggs were exposed to a low temperature (27°C) for approximately 2 h when the eggs were transferred from the incubator to the hatcher after injection on d 18 of incubation. It took another hour for the eggs to warm to the normal hatching temperature after they were set in the hatcher. Chicken embryos are unable to regulate their body temperature [26] , and a decrease in the environmental temperature causes a decrease in embryonic body temperature, followed by a decrease in embryonic metabolic rate, which subsequently delays the hatching process [27] . Suarez et al. [28] reported that incubation time was delayed as long as the time that embryos experienced cooling. Cooling embryos resulted in a longer incubation period. In the current study, when the embryos were moved out of the hatcher on d 21 of incubation, some of the embryos were still hatching. However, those embryos that hatched after d 21 of incubation were not counted in the calculation of hatchability. In the current study, hatchability was not affected by the injection of l-carnitine at concentrations of 8, 16, or 32 mg/100 μL as compared with the controls. This result is consistent with previous studies in which it was shown that the injection of l-carnitine had no detrimental effects on hatchability [9, 16, 23-25]. Keralapurath et al. [9] reported that l-carnitine levels at 0.5, 2.0, and 8.0 mg/100 μL of commercial diluent were nontoxic to broiler embryos. Results from the current study also confirmed that 8 mg of l-carnitine/100 μL of commercial diluent was nontoxic to broiler embryos.
After hatch, the grow-out phase began, and at 21 d of age, the birds that received the maximum in ovo injection dose of l-carnitine and fed diets supplemented with l-carnitine had reduced BW and feed consumption. Such reduction seemed to be less severe in those birds that received no l-carnitine or in birds that received lower doses of l-carnitine in ovo (Table 3 ). Mortality and FCR were unaffected by the injection and the feed supplementation of l-carnitine. l-Carnitine injection in combination with dietary l-carnitine supplementation was observed to reduce final 45-d BW and feed consumption ( Table 3) . The results observed at 21 and 45 d of age are not in agreement with results from previous studies in which l-carnitine supplementation had no effect on BW and feed intake [12, 29] . However, birds hatched from eggs that were only injected with 32 mg/100 μL of l-carnitine or that were injected with 8 or 16 mg/100 μL of l-carnitine in combination with subsequent dietary supplementation of 50 ppm of l-carnitine exhibited an improvement in feed conversion when compared with birds in the 3 control treatments. In several studies, dietary l-carnitine supplementation at 50, 75, 100, and 160 mg/kg to broilers was not toxic [4, 12, 14, 25] . However, it appears from the current results that 50 ppm of supplemental dietary l-carnitine in combination with 8, 16, and 32 mg/100 µL of l-carnitine administered via in ovo injection may be toxic to Values not sharing a common superscript within a column differ significantly. 1 Values correspond to feed conversion adjusted for mortality weight. broilers, as evidenced by the reductions in feed consumption, final BW, and breast meat weight. Among the slaughter yield parameters, only boneless-skinless breast meat weight was shown to be lower in birds fed 50 ppm of supplemental l-carnitine subsequent to the injection of 8 or 32 mg/100 μL of l-carnitine (Table 4 ). In contrast, breast meat weight was maximized in birds that were only injected with 8 mg/100 μL of lcarnitine. No responses to the treatments were observed with regard to back-half or abdominal fat weights or yields, in agreement with previous findings [12, 29] . Conversely, others have observed opposite results when supplemental lcarnitine was fed, with reductions in abdominal fat pad weight [11, 18] and increases in backhalf yield [30] .
In ovo injection with l-carnitine at levels ranging from 0 to 16 mg of l-carnitine/100 µL of diluent did not have any beneficial or deleterious effects on hatching, grow-out, or carcass trait production of broilers. At a level of 32 mg of l-carnitine/100 µL of diluent, a decrease in final feed consumption was observed, and the supplementation of l-carnitine via in ovo injection in combination with dietary supplementation resulted in reductions of final BW, feed consumption, and total breast meat weight, but it resulted in an improvement in feed conversion. Therefore, providing l-carnitine to broilers both in the feed and at the embryonic level via in ovo injection may have deleterious consequences that warrant further investigation. The in ovo application of l-carnitine at dosages of 8 or 16 mg/100 µL of diluent did not negatively affect broiler production or carcass traits, although it did fail to improve any of the parameters measured.
CONCLUSIONS AND APPLICATIONS
1. l-Carnitine in concentrations of 0 to 32 mg/100 μL of diluent did not have any effect on the hatching characteristics of injected eggs. 2. When eggs were injected with 32 mg of l-carnitine/100 μL of diluent, there was a decrease in final feed consumption. 3. The combination l-carnitine supplementation at 8, 16, or 32 mg/100 μL of diluent via in ovo injection with supple- 
